Leukemia & Lymphoma Society Specialized Center of Research (SCOR) Programme Open for Applications
Funding for teams of researchers engaged in collaborative projects to discover new approaches to treat blood cancers.
The Leukemia & Lymphoma Society (LLS) funds cutting-edge research around the world for every type of blood cancer, including leukaemia, lymphoma, myeloma, and other rare types of blood cancers.
LLS’s Specialized Center of Research (SCOR) grant programme is intended to bring together established investigators from one or several institutions to develop a focused research programme, foster new interactions and cooperation, and enhance interdisciplinary research among the participants. The overall goal of this approach is to enhance the development of innovative strategies for the treatment, diagnosis or prevention of haematological malignancies. Strategies that move discoveries from the bench to the clinic are of high importance as are integrated translational projects.
Each SCOR comprises 3-5 scientific Projects and 2-5 supportive Cores, including an administrative Core. There must be objective evidence of interdisciplinary research and the potential for synergism by linking the various Projects and Cores into a SCOR team. The quality and significance of the Projects and Cores and the enhanced productivity that is likely to be achieved by linking investigators are primary determinants of funding decisions.
A main emphasis in the SCOR grant programme is on clinical translation of scientific results. Preferably, a SCOR application will propose a combination of basic and translational laboratory research that will lead to eventual clinical translation.
Applications are welcome worldwide from not-for-profit academic institutions and researchers of any nationality.
Applicants must hold a PhD, MD, DVM, or equivalent degree and must be affiliated with a non-profit institution at the time funding commences and for the duration of the award. Applications may involve multiple institutions.
The maximum total award is $5 million over five years.
Letters of Intent should be submitted online by the deadline of 7 December 2023 (15:00 ET).
(This report was the subject of a RESEARCHconnect Newsflash.)